Literature DB >> 12485428

Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex.

Marcel F Jonkman1, Hendri H Pas, Miranda Nijenhuis, Guus Kloosterhuis, Gerritvander Steege.   

Abstract

Integrin alpha6beta4 is a hemidesmosomal transmembrane molecule involved in maintaining basal cell-matrix adhesion through interaction of the large intracytoplasmic tail of the beta4 subunit with the keratin intermediate filament network, at least in part through its binding with plectin and BP180/type XVII collagen. Here we report a patient with predominant features of epidermolysis bullosa simplex due to a mutation in the integrin beta4 gene. The patient, a 49-y-old female, had mild blistering of hands and feet from birth on, dystrophy of the nails with onychogryposis, and enamel hypoplasia. She had no alopecia and no history of pyloric atresia. Electron microscopy and antigen mapping of a skin blister revealed that the level of separation was intraepidermal, low in the basal keratinocytes through the attachment plaque of the hemidesmosome. Immuno-fluorescence microscopy revealed absent binding of monoclonal antibody 450-11 A against the third fibronectin III repeat on the intracellular domain of integrin beta4, whereas binding was reduced with monoclonal antibodies recognizing epitopes on amino-terminal and carboxy-terminal ends of the polypeptide. At the molecular level the phenotype was caused by a novel 2 bp deletion 4733delCT in ITGB4, resulting in in-frame skipping of exon 36 and a deduced 50 amino acid deletion (1450-1499) within the third fibronectin type III repeat in the cytoplasmic domain of the integrin beta4 polypeptide. Immunoblot analysis demonstrated a 5 kDa shorter beta4 polypeptide. The 4733delCT mutation was heterozygously present in the DNA. The patient is also expected to be heterozygous for a null allele, as no full-size protein was detected in vitro and the epitope 450-11 A was absent in vivo. These data show that deletion of the third fibronectin type III repeat in the cytoplasmic domain of integrin beta4, which is thought to interact with BP180/type XVII collagen, is clinically pathogenic and results in a mild phenotype with predominant features of epidermolysis bullosa simplex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12485428     DOI: 10.1046/j.1523-1747.2002.19609.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

Review 1.  Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis.

Authors:  Kevin Wilhelmsen; Sandy H M Litjens; Arnoud Sonnenberg
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

2.  Type XVII collagen regulates lamellipod stability, cell motility, and signaling to Rac1 by targeting bullous pemphigoid antigen 1e to alpha6beta4 integrin.

Authors:  Kevin J Hamill; Susan B Hopkinson; Marcel F Jonkman; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

Review 3.  Hemidesmosomes and focal contact proteins: functions and cross-talk in keratinocytes, bullous diseases and wound healing.

Authors:  Daisuke Tsuruta; Takashi Hashimoto; Kevin J Hamill; Jonathan C R Jones
Journal:  J Dermatol Sci       Date:  2011-01-21       Impact factor: 4.563

4.  Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC1).

Authors:  Hiroyuki Nakamura; Daisuke Sawamura; Maki Goto; Hideki Nakamura; James R McMillan; Susam Park; Sumio Kono; Shiro Hasegawa; Son'e Paku; Tomohiko Nakamura; Yoshihumi Ogiso; Hiroshi Shimizu
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

Review 5.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

6.  Defining the properties of the nonhelical tail domain in type II keratin 5: insight from a bullous disease-causing mutation.

Authors:  Li-Hong Gu; Pierre A Coulombe
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

Review 7.  Epidermolysis bullosa with pyloric atresia.

Authors:  Hye Jin Chung; Jouni Uitto
Journal:  Dermatol Clin       Date:  2010-01       Impact factor: 3.478

8.  Keratinocytes from patients lacking collagen XVII display a migratory phenotype.

Authors:  Kaisa Tasanen; Lucy Tunggal; Gretel Chometon; Leena Bruckner-Tuderman; Monique Aumailley
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

9.  The slingshot family of phosphatases mediates Rac1 regulation of cofilin phosphorylation, laminin-332 organization, and motility behavior of keratinocytes.

Authors:  Kristina Kligys; Jessica N Claiborne; Phillip J DeBiase; Susan B Hopkinson; Yvonne Wu; Kensaku Mizuno; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

10.  Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Authors:  Susanne Krämer; James Lucas; Francisca Gamboa; Miguel Peñarrocha Diago; David Peñarrocha Oltra; Marcelo Guzmán-Letelier; Sanchit Paul; Gustavo Molina; Lorena Sepúlveda; Ignacio Araya; Rubén Soto; Carolina Arriagada; Anne W Lucky; Jemima E Mellerio; Roger Cornwall; Fatimah Alsayer; Reinhard Schilke; Mark Adam Antal; Fernanda Castrillón; Camila Paredes; Maria Concepción Serrano; Victoria Clark
Journal:  Spec Care Dentist       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.